AbbVie Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A whale has taken a bearish stance on AbbVie (NYSE:ABBV), with 66% of detected unusual options trades being bearish. Whales have been targeting a price range of $80 to $160 for AbbVie over the last 3 months. Guggenheim, Wells Fargo, and Morgan Stanley maintain positive ratings on the stock.
May 22, 2023 | 7:45 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
A whale has taken a bearish stance on AbbVie, with 66% of detected unusual options trades being bearish. However, Guggenheim, Wells Fargo, and Morgan Stanley maintain positive ratings on the stock.
The bearish stance taken by the whale in the options market may create short-term downward pressure on AbbVie's stock price. However, the positive ratings from Guggenheim, Wells Fargo, and Morgan Stanley suggest that the stock's long-term prospects remain strong. As a result, the short-term impact on the stock price is neutral.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100